<DOC>
	<DOCNO>NCT00265616</DOCNO>
	<brief_summary>The purpose study determine whether propofol barbiturate prefer treatment status epilepticus ( continuous seizure activity ) refractory 2 standard antiepileptic agent .</brief_summary>
	<brief_title>Treatment Refractory Status Epilepticus</brief_title>
	<detailed_description>Refractory status epilepticus ( SE ) develop 31 % -44 % patient SE , mortality 16 % -23 % . Coma induction advocate management . Propofol barbiturates used agent , comparative study perform . In consideration uncertainty regard relative effectiveness , despite several retrospective data , prospective investigation need . The objective ass effectiveness ( SE control , adverse event ) first course propofol versus barbiturates treatment refractory SE , adult refractory SE due cerebral anoxia . Comparison : Coma induction standardize dos propofol barbiturate titrate towards burst-suppression EEG , assessment proportion patient achieve control SE .</detailed_description>
	<mesh_term>Status Epilepticus</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Thiopental</mesh_term>
	<mesh_term>Pentobarbital</mesh_term>
	<criteria>Patients refractory status epilepticus due cerebral anoxia , need coma induction clinical management . Age &lt; 16 year old . Known pregnancy . Cerebral anoxia SE etiology . Epilepsia partialis continuum ( simple partial SE ) . Known intolerance study drug . Known mitochondrial disorder , hyperlipidemia , significant rhabdomyolysis .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Refractory status epilepticus ,</keyword>
	<keyword>coma-induction ,</keyword>
	<keyword>treatment ,</keyword>
	<keyword>propofol ,</keyword>
	<keyword>barbiturate ,</keyword>
	<keyword>efficacy ,</keyword>
	<keyword>safety .</keyword>
</DOC>